The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis
Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review
56Citaten
(Scopus)
Vingerafdruk
Duik in de onderzoeksthema's van 'The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis'. Samen vormen ze een unieke vingerafdruk.
Keyphrases
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science